Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.

MLA

Cantini, Fabrizio, et al. “Tailored First-Line Biologic Therapy in Patients with Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis.” Seminars in Arthritis and Rheumatism, vol. 45, no. 5, Apr. 2016, pp. 519–32. EBSCOhost, https://doi.org/10.1016/j.semarthrit.2015.10.001.

APA

Cantini, F., Niccoli, L., Nannini, C., Cassarà, E., Kaloudi, O., Giulio Favalli, E., Becciolini, A., Biggioggero, M., Benucci, M., Li Gobbi, F., Grossi, V., Infantino, M., Meacci, F., Manfredi, M., Guiducci, S., Bellando-Randone, S., Matucci-Cerinic, M., Foti, R., Di Gangi, M., … Goletti, D. (2016). Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Seminars in Arthritis and Rheumatism, 45(5), 519–532. https://doi.org/10.1016/j.semarthrit.2015.10.001

Chicago

Cantini, Fabrizio, Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, Olga Kaloudi, Ennio Giulio Favalli, Andrea Becciolini, et al. 2016. “Tailored First-Line Biologic Therapy in Patients with Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis.” Seminars in Arthritis and Rheumatism 45 (5): 519–32. doi:10.1016/j.semarthrit.2015.10.001.